What About Caregiver-Centricity?
In recruiting and retaining patients for clinical trials, caregivers are occasionally mentioned but rarely prioritized. We know, however, that caregivers provide a wide range of
In recruiting and retaining patients for clinical trials, caregivers are occasionally mentioned but rarely prioritized. We know, however, that caregivers provide a wide range of
We collect so much information—there are data points everywhere, all filed into neat reports that you can color code or export to Excel or drop
Seemingly straightforward, the block-stacking game Jenga®️ is one that requires coordination, precision, and strategy. Finding the right block to move becomes increasingly difficult as the
Pharma avoids risks. Industry plays it safe. Uncertainty is discouraged, even dangerous. Sound familiar? The clinical side of pharma is more black and white than
“Feasibility” has become an umbrella term, applied to site selection criteria as well as protocol development and even patient-experience analysis—but it shouldn’t be. A “feasibility”
Managing large-scale projects as a program—comprised of a group of related projects—helps us achieve efficiencies and other benefits not available from managing the projects individually.
While the dedication to patient-centricity is present throughout all the work done at Continuum Clinical, nowhere is it more apparent than in the Advocacy Relations
In light of the seemingly constant reports of data breaches, hacking, and the unauthorized dissemination of personal data, data protection and security are increasingly important
Capturing the varying perspectives of all relevant stakeholders, journey mapping offers a multidisciplinary framework for streamlining and improving processes. By plotting the flow across touch
Real life patients stories started seeping into the pharma lexicon well over a decade ago, on both a commercial and research level. The industry began
2001 Pennsylvania Avenue, NW
Washington, D.C. 20006